ANA
PELETEIRO VIGIL
Investigadora en el periodo 2017-2022
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (6)
2024
-
Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxide
Biomedicine and Pharmacotherapy, Vol. 170
2023
-
Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key
International Journal of Molecular Sciences, Vol. 24, Núm. 13
2020
-
Cellular mechanisms accounting for the refractoriness of colorectal carcinoma to pharmacological treatment
Cancers, Vol. 12, Núm. 9, pp. 1-34
-
Molecular bases of mechanisms accounting for drug resistance in gastric adenocarcinoma
Cancers, Vol. 12, Núm. 8, pp. 1-29
2019
-
The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids Synthesis
Hepatology, Vol. 69, Núm. 4, pp. 1632-1647
2018
-
Interaction of glucocorticoids with FXR/FGF19/FGF21-mediated ileum-liver crosstalk
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 9, pp. 2927-2937